Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis

Diffuse alveolar hemorrhage (DAH) is a serious complication of the small vessel vasculitis syndromes and carries a high mortality. Recombinant activated factor VII (rFVIIa) is used to treat bleeding in patients with hemophilia and antibodies to factor VIII or IX. It is increasingly being used in lif...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoulani, Dania, Rao, Bharat, Khanshour, Ammar, Kuriakose, Philip, Yessayan, Lenar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119916/
https://www.ncbi.nlm.nih.gov/pubmed/25114814
http://dx.doi.org/10.1155/2014/283086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119916/
https://www.ncbi.nlm.nih.gov/pubmed/25114814
http://dx.doi.org/10.1155/2014/283086

Ejemplares similares